Search Results

Biologica Technologies, developers and marketers of ProteiOS® growth factor and OsseoGEN® cellular bone matrix, announced two significant, separate agreements signed with Premier Inc. and Academy Medical.

Advanced Biologics (known commercially as Biologica Technologies), a California-based company known for their innovative biologic solutions, announced today their successful merger with Isto Biologics, a global leader in regenerative and autologous therapies.

Biologica Technologies, developers and marketers of ProteiOS® growth factor and OsseoGEN® cellular bone matrix, announced today the podium presentation, ‘Retrospective assessment of radiographic outcomes after implantation of a novel allograft growth factor combined with scaffold in patients undergoing XLIF, LLIF, and TLIF procedures’

Biologica Technologies, developers and marketers of ProteiOS ® growth factor and OsseoGEN ® cellular bone matrix, announced today the early topline results from a retrospective, multicenter study evaluating the safety and effectiveness of ProteiOS in foot and ankle arthrodesis (fusion) procedures.

Silq Technologies announced its ClearTract® Foley Catheter has received an Innovative Technology contract from Vizient, Inc., the nation’s largest provider-driven healthcare performance improvement company.

Xironetic, a provider of augmented reality surgical guidance technology, is announcing the appointment of Jeff Potts to Chief Technology Officer.

Spineart, a fast-growing company specialized in spine surgery innovation, is pleased to announce the appointment of Laurent Nodé-Langlois as Chief Technology Officer.

AbTherx, Inc., a biotechnology company with innovative technologies that enable and accelerate antibody discovery, announced the opening of its new antibody discovery technologies research center.

SINTX Technologies, Inc. announced that its Board of Directors has initiated a process to explore potential strategic options for the Company.

Shineco Inc. announced that on June 18, 2024, it entered into an Investment Letter of Intent with Beijing Oriental Meitong Technology Co., Ltd. whereby Shineco intends to invest $20 million in Meitong Technology in exchange for 80% of Meitong Technology’s shares.